NasdaqCM - Delayed Quote USD

Baird Medical Investment Holdings Limited (BDMDW)

Compare
0.1300
+0.0500
+(62.50%)
At close: January 17 at 4:00:00 PM EST

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Haimei Wu Chairwoman of the Board of Directors & CEO 53.32k -- 1981
Ms. Quan Qiu Chief Administrative Officer & Executive Director 47.59k -- 1992
Mr. Wei Hou Executive Director 40.64k -- 1969
Ms. Jie Li Acting Chief Financial Officer -- -- 1987
Mr. Rongjian Lu CTO & Deputy GM -- -- 1966

Baird Medical Investment Holdings Limited

Room 202
2/F, Baide Building Building 11 No.15 Rongtong Street, Yuexiu District
Guangzhou, 510000
China
86 20 8218 5926 https://www.bairdmed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
148

Description

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Corporate Governance

Baird Medical Investment Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers